801. Vona M, Codeluppi GM, Iannino T, et al. Effects of different types of exercise training followed by detraining on endotheliumdependent dilation in
patients with recent myocardial infarction. Circulation 2009; 119: 1601-1608.
802. Ruygrok PN, Melkert R, Morel MA, et al. Does angiography six months after coronary intervention influence management and outcome? Benestent II
Investigators. J Am Coll Cardiol 1999; 34: 1507-1511.
803. Shimada K, Kasanuki H, Hagiwara N, et al. Routine coronary angiographic follow-up and subsequent revascularization in patients with acute
myocardial infarction. Heart Vessels 2008; 23: 383-389.
804. Deleted in proof.
805. 循環器病の診断と治療に関するガイドライン.心疾患患者の学校,職域,スポーツにおける運動許容条件に関するガイドライ ン(2008年改訂版).
http://www.j-circ.or.jp/guideline/pdf/JCS2008_nagashima_h.pdf(2012年12月閲覧)
806. Pasternak RC. Comprehensive rehabilitation of patients with cardiovascular disease. In: Zipes DP, Libby P, Bonow RO, Braunwald E, eds.
Braunwald's heart disease: a textbook of cardiovascular medicine, 7th edn. Elsevier Saunders, 2005; 1085-1102.
807. Gibbons RJ, Balady GJ, Bricker JT, et al: ACC/AHA 2002 guideline update for exercise testing: a report of the American College of
Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). http://www. acc.org/clinical/guidelines/
exercise/dirIndex.htm
808. Froom P, Cohen C, Rashcupkin J, et al. Referral to occupational medicine clinics and resumption of employment after myocardial infarction. J Occup
Environ Med 1999; 41: 943-947.
809. Boudrez H, De Backer G. Recent findings on return to work after an acute myocardial infarction or coronary artery bypass grafting. Acta Cardiol 2000;
55: 341-349.
810. Mittag O, Kolenda KD, Nordman KJ, et al. Return to work after myocardial infarction/coronary artery bypass grafting: patients' and physicians' initial
viewpoints and outcome 12 months later. Soc Sci Med 2001; 52: 1441-1450.
811. Petrie KJ, Cameron LD, Ellis CJ, et al. Changing illness perceptions after myocardial infarction: an early intervention randomized controlled trial.
Psychosom Med 2002; 64: 580-586.
812. Brodie B, Grines CL, Spain M, et al. 901-1 A prospective, randomized trial evaluating early discharge (day 3) without non-invasive risk stratification
in low risk patients with acute myocardial infarction: PAMI-2. J Am Coll Cardiol 1995; 25: 5A.
813. ENRICHD Investigators. Enhancing Recovery in Coronary Heart Disease (ENRICHD) study intervention: rationale and design. Psychosom Med 2001;
63: 747-755.
814. Bush DE, Ziegelstein RC, Tayback M, et al. Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J
Cardiol 2001; 88: 337-341.
815. Swenson JR, O'Connor CM, Barton D, et al; Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) Group.. Influence of depression
and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome. Am J Cardiol 2003; 92: 1271-1276.
816. Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction:
the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003; 289: 3106-3116.
817. Case RB, Moss AJ, Case N, et al. Living alone after myocardial infarction. Impact on prognosis. JAMA 1992; 267: 515-519.
818. McCartney N. Role of resistance training in heart disease. Med Sci Sports Exerc 1998; 30: S396-402.
819. Miller NH, Taylor CB. Education, communication, and methods of intervention. In: Miller NH, Taylor CB. Lifestyle Management for Patients with
Coronary Heart Disease (Current Issues in Cardiac Rehabilitation, Monograph no. 2). Human Kinetics 1995: 21-30.
820. Linden W. Psychological treatments in cardiac rehabilitation: review of rationales and outcomes. J Psychosom Res 2000; 48: 443-454.
821. Crowe JM, Runions J, Ebbesen LS, et al. Anxiety and depression after acute myocardial infarction. Heart Lung 1996; 25: 98-107.
822. Izawa KP, Watanabe S, Oka K, et al. Age-related differences in physiologic and psychosocial outcomes after cardiac rehabilitation.
Am J Phys Med Rehabil 2010; 89: 24-33.
823. 第5次医療法改正.http://www.monju-jp.com/pub/iryouhoukaisei0703.html(2012年12月閲覧)
824. 田城孝雄.竹田綜合病院におけるプロトタイプ循環器連携パス.治療 2008; 90: 944-953.
825. 石木良治.トヨタ記念病院の循環器連携体制.治療 2008; 90: 954-960.
826. 町田陽二,東條美奈子,和泉徹,他.北里大学東病院心臓二次予防センターでの試み―増悪・再発予防.治療 2008; 90: 961-967.
827. 平松義博,野田喜寛,後藤葉一,他.心臓リハビリテーション パネルディスカッション 地域連携の現状と課題(まとめ).心臓リハ 2011; 16: 81-84.
828. 循環器病の診断と治療に関するガイドライン.循環器疾患における抗凝固・抗血小板療法に関するガイドライン(2009年改訂版).
http://www.j-circ.or.jp/guideline/pdf/JCS2009_hori_h.pdf(2012年12月閲覧)
829. Kandzari DE, Angiolillo DJ, Price MJ, et al. Identifying the "optimal" duration of dual antiplatelet therapy after drug-eluting stent revascularization.
JACC Cardiovasc Interv 2009; 2: 1279-1285.
830. Harjai KJ, Shenoy C, Orshaw P, et al. Dual antiplatelet therapy for more than 12 months after percutaneous coronary intervention: insights from the
Guthrie PCI Registry. Heart 2009; 95: 1579-1586.
831. Park SJ, Park DW, Kim YH, et al. Duration of dual antiplatelet therapy after implantation of drug-eluting stents. N Engl J Med 2010; 362: 1374-1382.
832. Smith SC, Feldman TE, Hirshfeld JW, et al. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention ―summary article: a
report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to
Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006; 113: 156-175.
833. Pinto Slottow TL, Waksman R. Overview of the 2006 Food and Drug Administration Circulatory System Devices Panel meeting on drug-eluting stent
thrombosis. Catheter Cardiovasc Interv 2007; 69: 1064-1074.
834. Tada T, Natsuaki M, Morimoto T, et al. Duration of dual antiplatelet therapy and long-term clinical outcome after coronary drug-eluting stent
implantation: landmark analyses from the CREDO-Kyoto PCI/CABG Registry Cohort-2. Circ Cardiovasc Interv 2012; 5: 381-391.
835. Ray WA, Murray KT, Griffin MR, et al. Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study. Ann Intern Med
2010; 152: 337-345.
836. Douglas IJ, Evans SJ, Hingorani AD, et al. Clopidogrel and interaction with proton pump inhibitors: comparison between cohort and within person
study designs. BMJ 2012; 345: e4388.
837. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-874.
838. Phrommintikul A, Kuanprasert S, Wongcharoen W, et al. Influenza vaccination reduces cardiovascular events in patients with acute coronary
syndrome. Eur Heart J 2011; 32: 1730-1735.
839. Johnstone J, Loeb M, Teo KK, et al. Influenza vaccination and major adverse vascular events in high-risk patients. Circulation 2012; 126: 278-286.
840. Tseng HF, Slezak JM, Quinn VP, et al. Pneumococcal vaccination and risk of acute myocardial infarction and stroke in men. JAMA 2010; 303: 1699-
1706.
841. Granger CB, Henry TD, Bates WE, et al. Development of systems of care for ST-elevation myocardial infarction patients: the primary percutaneous
coronary intervention (ST-elevation myocardial infarction-receiving) hospital perspective. Circulation 2007; 116: e55-59.
842. Williams SC, Schmaltz SP, Morton DJ, et al. Quality of care in U.S. hospitals as reflected by standardized measures, 2002-2004. N Engl J Med
2005; 353: 255-264.
843. Krumholz HM, Anderson JL, Brooks NH, et al. ACC/AHA clinical performance measures for adults with ST-elevation and non-STelevation myocardial
infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to
Develop Performance Measures on ST-Elevation and Non-ST-Elevation Myocardial Infarction). J Am Coll Cardiol 2006; 47: 236-265.
844. Roe MT, Parsons LS, Pollack CV, et al. National Registry of Myocardial Infarction Investigators. Quality of care by classification of myocardial
infarction: treatment patterns for ST-segment elevation vs non-ST-segment elevation myocardial infarction. Arch Intern Med 2005; 165: 1630-1636.
845. Hamm CW, Bassand JP, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent
ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment
elevation of the European Society of Cardiology (ESC). Eur Heart J 2011; 32: 2999-3054.
846. Kushner FG, Hand M, Smith SC, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial
infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the
2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on
Practice Guidelines. J Am Coll Cardiol 2009; 54: 2205-2241.
847. Hannan EL, Wu C, Walford G, et al. Volume-outcome relationships for percutaneous coronary interventions in the stent era. Circulation 2005; 112:
1171-1179.
848. Post PN, Kuijpers M, Ebels T, et al. The relation between volume and outcome of coronary interventions: a systematic review and meta-analysis. Eur
Heart J 2010; 31: 1985-1992.
849. Wijns W, Kolh PH. Experience with revascularization procedures does matter: low volume means worse outcome. Eur Heart J 2010; 31: 1954-1957.
850.( 一般社団法人)日本心血管インターベンション治療学会ホームページ. http://www.cvit.jp/registry/(2012年12月閲覧)
851. Kumbhani DJ, Cannon CP, Fonarow GC, et al. Get With the Guidelines Steering Committee and Investigators. Association of hospital primary
angioplasty volume in ST-segment elevation myocardial infarction with quality and outcomes. JAMA 2009; 302: 2207-2213.
852. 東海林哲郎.心疾患に対する救急医療に関する診療の手引き,厚生省循環器病研究委託費9指―2.市民への啓蒙―急性心筋梗塞発症早期受診の重要性
(野々木宏,編).2000: 98-103.
853. Faxon D, Lenfant C. Timing is everything: motivating patients to call 9-1-1 at onset of acute myocardial infarction. Circulation 2001; 104: 1210-1211.
854. 笠貫宏,高山守正.急性冠症候群患者の安定化.AHA心肺蘇生と救急心血管治療のためのガイドライン2005(日本語版). Japan Resuscitation Council and
American Heart Association 2006: 118-142.
855. 日本版救急蘇生ガイドライン策定小委員会.救急蘇生法の指針─市民用.へるす出版 2006.
856. 急性心筋梗塞(ST上昇型)の診療に関するガイドライン.Circ J 2008; 72, Suppl. IV: 1347-1442.
857. 笠貫宏(班長).(2007-2008年度合同研究班報告) I.2. 循環器救急の現況と課題.循環器医のための心肺蘇生・心血管救急に関するガイドライン.Circ J
2009; 73, Suppl. III: 1364-1366.
858. Nallamothu BK, Krumholz HM, Peterson ED, et al. D2B Alliance and the American Heart Association Get-With-The-Guidelines Investigators. Door-to-
balloon times in hospitals within the get-with-the-guidelines registry after initiation of the door-toballoon (D2B) Alliance. Am J Cardiol 2009; 103: 1051-
1055.
859. Heidenreich PA, Lewis WR, LaBresh KA, et al. Hospital performance recognition with the Get With The Guidelines Program and mortality for acute
myocardial infarction and heart failure. Am Heart J 2009; 158: 546-553